Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 7 Prostatic Neoplasms 6 Hematopoietic and Lymphatic System Neoplasm 6 Hematologic Neoplasms 6 Colorectal Neoplasms 5 Breast Neoplasms 5 Anatomic Stage I Breast Cancer AJCC v8 5 Pancreatic Neoplasms 3 Neoplasms 3 Malignant Solid Neoplasm 3 Leukemia, Myeloid, Acute 3 Urinary Bladder Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Ovarian Neoplasms 2 Mouth Neoplasms 2 Melanoma 2 Head and Neck Carcinoma 2 Glioma 2 Carcinoma, Renal Cell 2 Carcinoma 2 COVID-19 2 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Urologic Neoplasms 1 Urologic Diseases 1 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1 Tonsillar Neoplasms 1 Tongue Neoplasms 1 Teratoma 1

Interventions

Paclitaxel 6 Mitomycin 3 Carboplatin 3 Bevacizumab 3 sodium thiosulfate 2 Laparoscopy 2 Hyperthermic Intraperitoneal Chemotherapy 2 Cisplatin 2 relacorilant 1 pembrolizumab 1 oregovomab 1 olaparib 1 nilotinib 1 liposomal doxorubicin 1 Topotecan 1 Taxes 1 Standard of Care 1 Specimen Handling 1 Saline Solution 1 Practice Guidelines as Topic 1 Pancreatectomy 1 Oxaliplatin 1 Magnetic Resonance Spectroscopy 1 Laparotomy 1 Glucose 1 Gemcitabine 1 Fluorouracil 1 Electrocardiography 1 Doxorubicin 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Peritoneal Neoplasms × Practice Guidelines as Topic × 90 days × Clear all

NCT07001748 2026-05-15

STOPGAP II

Eastern Cooperative Oncology Group

Phase 2/3 Recruiting

Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡